ARTICLE | Distillery Therapeutics
Therapeutics: Sirtuin 2 (SIRT2); v-myc myelocytomatosis viral oncogene homolog (MYC; c-Myc)
March 24, 2016 7:00 AM UTC
In vitro, cell and mouse studies identified a thioacyl lysine-based SIRT2 inhibitor that could help treat breast cancer. Chemical synthesis and in vitro testing of thioacyl lysine analogs identified a...